AI enhanced Mammography Screening Market

Future Market Insights

AI enhanced Mammography Screening Market

Key Insight

The Global AI enhanced Mammography Screening Market is projected to grow from USD 159.6 million in 2025 to USD 364.1 million by 2035, at a CAGR of 8.6%. By type, Computer-Aided Detection (CADe) will dominate with a 35.7% market share, while 2D Digital Mammography (FFDM) will lead the Imaging Technology segment with a 41.7% share in 2025.

September 30, 2025

Anurag Sharma

250 Pages

Cite this Report

AI enhanced Mammography Screening Market

https://www.futuremarketinsights.com/reports/ai-enhanced-mammography-screening-market

License

Buy Now

Summary ToC Companies

Key Players

Hologic, Inc.
iCAD
Inc. (DeepHealth)
MammoScreen
Therapixel
ScreenPoint Medical BV
Envisionit Deep AI (Pty) Ltd.
Human Bytes
Planmed Oy
Analogic Corporation
GE HealthCare
Koninklijke Philips N.V.
Esaote SPA

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

AI enhanced Mammography Screening Market

Key Players

Similar Industry Reports